Neurotrack is transforming the diagnosis of Alzheimer’s disease. Through a safe and non-invasive test, its technology can predict the risk of developing mild cognitive impairment and Alzheimer’s disease years before symptoms occur.
|HQ||Redwood City, US|
|Size (employees)||25 (est)+5%|
Neurotrack total Funding
Neurotrack latest funding size
Time since last funding
|7 months ago|
|iSeed Ventures, Rock Health, Khosla Ventures, Social Capital, AME Cloud Partners, Founders Fund, AME Cloud Ventures, Sozo Ventures, Rethink Impact, Marc Benioff|